BIO Names Sen. Christopher Bond a Legislator of the Year
“Senator Bond has been a tireless advocate of international agricultural biotechnology,” said BIO President Carl B. Feldbaum. “Through his work, organizations including the U.S. Agency for International Development and the National Science Foundation have received funding to spark more biotechnology research in the developing world, where new agricultural technologies are desperately needed.
“The biotech industry has always considered Senator Bond a champion of biotechnology’s potential, which is reflected in the industry’s growth in his home state of Missouri.
“He has also taken a strong stand against the European Union’s moratorium on
approving new products derived through agricultural biotechnology, and has been a consistent voice against non-tariff trade barriers against these same products,” said Feldbaum.
More than 230 congressional meetings with more than 160 industry representatives
were held on Capitol Hill today, during BIO’s annual Legislative Day event. Participants discussed important biotechnology issues, including the reauthorization of the Prescription Drug User Fee Act, Medicare reform, prescription drug coverage, and reducing trade barriers for American farmers.
BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products.
# # #